阿斯坦丁通过调节PTP1B/JNK通路在体外抑制LPS诱导的心肌亡
Wen-Jie Xie1, Miao Liu2, Xu Zhang3
1Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
International immunopharmacology
|December 23, 2023
概括
阿斯塔克桑丁 (ATX) 通过抑制亡,防止败血症引起的心肌损伤. ATX 向蛋白氨酸酸酶1B (PTP1B) 并抑制 JNK 信号通路,减少细胞死亡.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 败血症研究 败血症研究
背景情况:
- 败血症引起的心肌损伤是死亡的一个重要原因.
- 心肌亡在感染性心肌损伤的发病过程中起着至关重要的作用.
- 阿斯塔克桑丁 (ATX) 正在研究其潜在的心脏保护作用.
研究的目的:
- 在体外探索阿斯塔ξαν丁 (ATX) 抑制脂多糖 (LPS) 诱导的心肌亡的机制.
- 确定ATX对抗败血性心肌损伤的保护作用所涉及的分子标和信号通路.
主要方法:
- 用LPS和不同度的ATX,PTP1B抑制剂或JNK激活剂对待H9C2细胞.
- 评估了细胞活力 (CCK-8测定),细胞亡 (流细胞计) 和线粒体膜潜力 (JC-1染色).
- 预测了ATX的分子标 (SwissTargetPrediction) 并验证了 (MST);分析了PTP1B,JNK和p-JNK的蛋白质表达 (西方斑点,免疫光).
主要成果:
- ATX增强了H9C2细胞活力,并抑制了LPS诱导的亡和线粒体功能障碍.
- 蛋白氨酸酸酶1B (PTP1B) 被确定为ATX的直接目标.
- ATX减弱了LPS诱导的PTP1B和p-JNK表达,并通过PTP1B/JNK通路抑制了亡.
结论:
- 阿斯塔克桑丁 (ATX) 有效地抑制H9C2细胞中脂聚糖 (LPS) 诱导的线粒体亡.
- 保护机制涉及PTP1B/JNK信号通路,PTP1B被确定为ATX的直接分子标.
- ATX显示了缓解与败血症相关的心肌损伤的显著潜力.
更多相关视频
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.2K
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
687
相关概念视频
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
